PCVX vs GILD: Which Stock is Better?
Side-by-side comparison of Vaxcyte Inc and Gilead Sciences Inc in 2026
PCVX
Vaxcyte Inc
—
GILD
Gilead Sciences Inc
$136.30
Key Metrics Comparison
| Metric | PCVX | GILD | Winner |
|---|---|---|---|
| Market Cap | $6.84B | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PCVX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCVX or GILD a better investment?
Comparing PCVX and GILD: Vaxcyte Inc has a market cap of $6.84B while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCVX and GILD?
PCVX (Vaxcyte Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCVX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PCVX or GILD?
Both PCVX and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PCVX or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PCVX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $6.84B for PCVX.
Should I buy PCVX or GILD in 2026?
Both PCVX and GILD have investment merit. PCVX trades at $N/A while GILD trades at $136.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCVX and GILD stock?
Key differences: Market Cap ($6.84B vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PCVX or GILD in 2026?
The choice between PCVX and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PCVX and GILD?
PCVX (Vaxcyte Inc) has a market cap of $6.84B, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.